Delivery Order SPE2DB20D1100-SPE2DB25FZ12F
Award Date
11/19/24
Potential Completion Date
11/20/24
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,361.24, is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, and has a completion date of December 19, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $4,664.55, is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025 and is a Firm Fixed Price Delivery Order. There is no set-aside designation mentioned. AmerisourceBergen Drug Corp has a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,104.73, is for the delivery of BUDESONIDE-FORMOTEROL 80-4.5 10.2GM, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 21, 2025. The contract award is not designated as a set-aside. AmerisourceBergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,553.53, is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a medical product used in healthcare settings. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 7, 2025. The contract does not have a set-aside designation,...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,910.28, is for the supply of BUDESONIDE-FORMOTEROL 80-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of December 5, 2024 and is a Firm Fixed Price contract. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,278.81 firm fixed-price delivery order is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a respiratory medication. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $1,014.30 and has a completion date of February 6, 2025. It is for the supply of 4567175524 BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, to support military healthcare programs. The contract has no set-aside designation, indicating open competition. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an award value of $2,647.56 and is a Firm Fixed Price Delivery Order for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,793.42 firm fixed-price contract is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a medical product, with a period of performance through December 16, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $4,126.52, with a firm fixed price and a ceiling value of $4,126.52. The contract is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...